Research

Cellular

C-reactive protein levels decreased after one year of GLP1-RA treatment.

Monitoring C-reactive protein levels may help assess the effectiveness of GLP1-RA in IBD.

StrongSupportsmedium confidence
C-reactive protein levels decreased after one year ( P = 0.005).
Scott R. Anderson et al. · The American Journal of Gastroenterology · 2024

Why this rating

The study involved a retrospective analysis of 120 patients.

Source

Safety and Effectiveness of Glucagon-like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease

Scott R. Anderson et al. · The American Journal of Gastroenterology · 2024

DOI 10.14309/ajg.0000000000003208

cohort · n=120Cited 23×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →